UK Markets open in 4 hrs 35 mins

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
38.36-0.96 (-2.44%)
At close: 4:00PM EDT
38.36 0.00 (0.00%)
After hours: 04:56PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 522.77B
Enterprise value 337.38B
Trailing P/E 16.65
Forward P/E 111.55
PEG ratio (5-yr expected) 13.54
Price/sales (ttm)1.30
Price/book (mrq)1.87
Enterprise value/revenue 32.13
Enterprise value/EBITDA 712.12

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 344.94
52-week low 333.84
50-day moving average 341.09
200-day moving average 339.00

Share statistics

Avg vol (3-month) 3246.48k
Avg vol (10-day) 3403.04k
Shares outstanding 5585.78M
Implied shares outstanding 6N/A
Float 397.16M
% held by insiders 10.00%
% held by institutions 13.31%
Shares short (14 Jun 2021) 4520.43k
Short ratio (14 Jun 2021) 43.01
Short % of float (14 Jun 2021) 4N/A
Short % of shares outstanding (14 Jun 2021) 40.09%
Shares short (prior month 13 May 2021) 4346.69k

Dividends & splits

Forward annual dividend rate 40.82
Forward annual dividend yield 41.97%
Trailing annual dividend rate 31.34
Trailing annual dividend yield 33.41%
5-year average dividend yield 4N/A
Payout ratio 431.17%
Dividend date 306 Jun 2021
Ex-dividend date 423 May 2021
Last split factor 22:1
Last split date 303 Dec 2012

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021


Profit margin 6.43%
Operating margin (ttm)12.85%

Management effectiveness

Return on assets (ttm)4.20%
Return on equity (ttm)10.50%

Income statement

Revenue (ttm)17.58B
Revenue per share (ttm)30.02
Quarterly revenue growth (yoy)-6.20%
Gross profit (ttm)5.54B
Net income avi to common (ttm)1.13B
Diluted EPS (ttm)2.30
Quarterly earnings growth (yoy)-11.90%

Balance sheet

Total cash (mrq)1.07B
Total cash per share (mrq)1.83
Total debt (mrq)12.9B
Total debt/equity (mrq)97.74
Current ratio (mrq)1.08
Book value per share (mrq)20.48

Cash flow statement

Operating cash flow (ttm)3.86B
Levered free cash flow (ttm)2.25B